Leaflet DITAGFENDA 240mg gastro-resistant capsules


Indicated for: multiple sclerosis

Substance: dimethyl fumarate (immunomodulator)

ATC: L04AX07 (Antineoplastic and immunomodulating agents | Immunosuppressants | Other immunosuppressants)

Dimethyl fumarate is a medication used for the treatment of relapsing-remitting multiple sclerosis. It works by reducing inflammation and protecting nerve cells from oxidative stress.

The medication is taken orally, usually twice daily, as directed by a doctor. It is important to follow the recommended dose to minimize the risk of adverse effects.

Side effects may include flushing, nausea, diarrhea, abdominal pain, or a decrease in lymphocyte count. In rare cases, severe allergic reactions or progressive multifocal leukoencephalopathy may occur.

Dimethyl fumarate is not recommended for patients with hypersensitivity to this medication or active severe infections.

General data about DITAGFENDA 240mg

  • Substance: dimethyl fumarate
  • Date of last drug list: 01-10-2024
  • Commercial code: W70561001
  • Concentration: 240mg
  • Pharmaceutical form: gastro-resistant capsules
  • Quantity: 56
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: PHARMADOX HEALTHCARE LTD. - MALTA
  • Holder: ADALVO LIMITED - ROMANIA
  • Number: 15604/2024/01
  • Shelf life: 3 years

Pharmaceutical forms available for dimethyl fumarate

Concentrations available for dimethyl fumarate

  • 120mg
  • 240mg
  • 30mg